All News about Lexaria Bioscience Corp
Lexaria Announces Ambitious New Hypertension Study HYPER-H21-4
November 03, 2021
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
Lexaria Announces R&D Program to Compare First and Only FDA-Approved Prescription Cannabidiol
November 01, 2021
Via AccessWire
Topics
Intellectual Property
Exposures
Intellectual Property
CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Impacting the Pharmaceutical Industry
October 19, 2021
Via CannabisNewsWire
Topics
Cannabis
Exposures
Cannabis
CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH(TM) Impacting the Pharmaceutical Industry
October 19, 2021
Topics
Cannabis
Exposures
Cannabis
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|